Is contact between men who have sex with men and non-governmental organizations providing harm reduction associated with improved HIV outcomes?


Journal

HIV medicine
ISSN: 1468-1293
Titre abrégé: HIV Med
Pays: England
ID NLM: 100897392

Informations de publication

Date de publication:
04 2021
Historique:
accepted: 09 10 2020
pubmed: 13 11 2020
medline: 15 3 2022
entrez: 12 11 2020
Statut: ppublish

Résumé

There is a high prevalence of HIV (5.2% in 2018) among men who have sex with men (MSM) in Ukraine. HIV testing, condom provision and facilitated linkage to HIV treatment have been funded by various bodies through non-governmental organizations (NGOs). We investigated whether contact with these NGOs was associated with improved prevention and treatment outcomes among MSM in Ukraine. Data were taken from four rounds of integrated bio-behavioural surveys among MSM in Ukraine (2011, N = 5950; 2013, N = 8101; 2015, N = 4550; 2018, N = 5971) including HIV testing combined with questionnaire responses. Data were analysed using mixed-effect regression models, which estimated associations between being an NGO client and behavioural, HIV testing and HIV treatment outcomes, adjusted for demographic factors. Those MSM who were NGO clients were more likely than non-clients to have been HIV tested in the last year [adjusted odds ratio (aOR) = 7.01, 95% confidence interval (CI): 6.45-7.62] or ever (aOR = 11.00, 95% CI: 9.77-12.38), to have used a condom for the last anal sex act (aOR = 1.32, 95% CI: 1.21-1.43), and to have recently either bought or received condoms (aOR = 21.27, 95% CI: 18.01-25.12). HIV-positive MSM were more likely to have contact with NGOs (aOR = 1.61, 95% CI: 1.39-1.86). Among the HIV-positive MSM, those who were NGO clients were more likely to be registered at an AIDS centre (aOR = 2.24, 95% CI: 1.61-3.11) and to be on antiretroviral treatment (aOR = 2.20, 95% CI: 1.51-3.20). In Ukraine, being in contact with MSM-targeted NGOs is associated with better outcomes for HIV prevention, testing and treatment, suggesting that NGO harm reduction projects for MSM have had a beneficial impact on reducing HIV transmission and morbidity.

Identifiants

pubmed: 33179855
doi: 10.1111/hiv.13010
pmc: PMC7984049
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

262-272

Subventions

Organisme : NIDA NIH HHS
ID : R01DA033679
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA033679
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI147490
Pays : United States
Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

© 2020 The Authors. HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association.

Références

BMC Med Res Methodol. 2019 Oct 29;19(1):202
pubmed: 31664912
PLoS One. 2015 Aug 31;10(8):e0137062
pubmed: 26322977
PLoS One. 2014 Sep 24;9(9):e103657
pubmed: 25251080
BMC Public Health. 2014 Aug 03;14:784
pubmed: 25086742
BMC Infect Dis. 2018 Aug 20;18(1):410
pubmed: 30126355
Int J STD AIDS. 2018 Nov;29(13):1337-1344
pubmed: 30049259
Lancet HIV. 2019 May;6(5):e283-e296
pubmed: 30952565
AIDS Care. 2010 Apr;22(4):409-14
pubmed: 20131126
BMJ. 2004 Jul 24;329(7459):185-6
pubmed: 15271806
Lancet HIV. 2017 Nov;4(11):e482-e483
pubmed: 29066095
J Int AIDS Soc. 2017 Jun 28;20(1):21579
pubmed: 28691435
Clin Infect Dis. 2015 Dec 1;61(11):1732-41
pubmed: 26251048
Lancet HIV. 2017 Aug;4(8):e349-e356
pubmed: 28501495
J Int AIDS Soc. 2017 Nov;20(3):
pubmed: 29105323
N Engl J Med. 2016 Sep 1;375(9):830-9
pubmed: 27424812
J Int AIDS Soc. 2020 Aug;23(8):e25608
pubmed: 32851812
Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1051-1056
pubmed: 29339468
AIDS Res Hum Retroviruses. 2014 May;30(5):407-8
pubmed: 24295084
AIDS Res Hum Retroviruses. 2007 Nov;23(11):1338-47
pubmed: 18184075
N Engl J Med. 2015 Dec 3;373(23):2237-46
pubmed: 26624850
AIDS Behav. 2018 Jun;22(6):1955-1964
pubmed: 29218602
Lancet. 2012 Jul 28;380(9839):367-77
pubmed: 22819660
Curr HIV/AIDS Rep. 2009 Nov;6(4):177-86
pubmed: 19849960

Auteurs

A Trickey (A)

Population Health Sciences, University of Bristol, Bristol, UK.

J Stone (J)

Population Health Sciences, University of Bristol, Bristol, UK.

N Semchuk (N)

Alliance for Public Health, Kiev, Ukraine.

T Saliuk (T)

Alliance for Public Health, Kiev, Ukraine.

Y Sazonova (Y)

Alliance for Public Health, Kiev, Ukraine.

O Varetska (O)

Alliance for Public Health, Kiev, Ukraine.

A G Lim (AG)

Population Health Sciences, University of Bristol, Bristol, UK.

J G Walker (JG)

Population Health Sciences, University of Bristol, Bristol, UK.

P Vickerman (P)

Population Health Sciences, University of Bristol, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH